EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Construction and Validation of a Nomogram Prediction Model for the Risk of Cefoperazone Sodium/Sulbactam Sodium-Related Coagulation Disorders

Mengjun Min, Jing Zeng, Mingyue Zou, Yingxian Peng

Infection and Drug Resistance · 2025-08 · Volume 18 · 3859-3866

DOI: 10.2147/idr.s534366 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Infection and Drug Resistance, 2025-08. Verfasst von Mengjun Min und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The Sixth Hospital of Wuhan, Affiliated Hospital of Jianghan University, Wuhan, People's Republic of China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To construct and validate a nomogram prediction model for the risk of cefoperazone sodium/sulbactam sodium (CPZ/SAM)-related coagulation disorders in hospitalized patients.

Methods

Patients treated with CPZ/SAM from January 2022 to December 2024 were enrolled and divided into a coagulation disorder group and a control group based on the occurrence of coagulation disorders. Clinical data were collected to identify risk factors and construct a nomogram model, which was validated using the Hosmer-Lemeshow goodness-of-fit test, receiver operating characteristic (ROC) curve, decision curve analysis (DCA), and clinical impact curve.

Results

A total of 439 patients were included, with 86 cases (19.59%) in the coagulation disorder group and 353 cases in the control group. Multivariate analysis identified malnutrition, recent bleeding history, prolonged treatment duration with CPZ/SAM, combination use with carbapenems, and elevated serum creatinine as independent risk factors. The constructed nomogram had an AUC of 0.845, demonstrating good calibration ability (χ²=2.312, P=0.891), providing moderate net benefit in predicting the incidence of coagulation disorders, with consistent agreement between predicted and actual probabilities.

Conclusion

The nomogram model effectively identifies high-risk patients, indicating that attention should be paid to the risk of coagulation disorders in patients with the above risk factors during CPZ/SAM treatment.

Schlagwörter

Stichwörter der Autor:innen

antimicrobial stewardshipcefoperazone sodium/sulbactam sodiumcoagulation disordersnomogrampredictive model

Autor:innen und Institutionen

  • Department of Pharmacy, The Sixth Hospital of Wuhan, Affiliated Hospital of Jianghan University, Wuhan, People's Republic of China.
  • Department of Pharmacy, Hubei No. 3 People's Hospital of Jianghan University, Wuhan, People's Republic of China.

Zitieren

APA

Min, M., Zeng, J., Zou, M., & Peng, Y. (2025). Construction and Validation of a Nomogram Prediction Model for the Risk of Cefoperazone Sodium/Sulbactam Sodium-Related Coagulation Disorders. Infection and Drug Resistance, Volume 18, 3859-3866. https://doi.org/10.2147/idr.s534366

Vancouver

Min M, Zeng J, Zou M, Peng Y. Construction and Validation of a Nomogram Prediction Model for the Risk of Cefoperazone Sodium/Sulbactam Sodium-Related Coagulation Disorders. Infection and Drug Resistance. 2025;Volume 18:3859-3866. doi:10.2147/idr.s534366

BibTeX
@article{Min2025,
  author = {Min, Mengjun and Zeng, Jing and Zou, Mingyue and Peng, Yingxian},
  title = {Construction and Validation of a Nomogram Prediction Model for the Risk of Cefoperazone Sodium/Sulbactam Sodium-Related Coagulation Disorders},
  journal = {Infection and Drug Resistance},
  year = {2025},
  volume = {Volume 18},
  pages = {3859--3866},
  doi = {10.2147/idr.s534366}
}
Kostenlos starten →